These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15255556)

  • 1. Role of levofloxacin in the treatment of lower respiratory tract infections (LRTIs).
    Blasi F
    J Chemother; 2004 Apr; 16 Suppl 2():11-4. PubMed ID: 15255556
    [No Abstract]   [Full Text] [Related]  

  • 2. Levofloxacin PK/PD: from sequential therapy model to high dosage for critical patients.
    Pea F; Furlanut M
    J Chemother; 2004 Apr; 16 Suppl 2():8-10. PubMed ID: 15255555
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of levofloxacin in the treatment of respiratory tract infection.
    Shah PM
    J Chemother; 2000 Oct; 12 Suppl 4():27-31. PubMed ID: 11131957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The first 'respiration' fluoroquinolone--levofloxacin (Tavanic) in therapy of bacterial infections. Pharmacodynamics principles in optimization of administration regimens].
    Budanov SV; Vasil'ev AN; Smirnova LB
    Antibiot Khimioter; 2001; 46(7):38-46. PubMed ID: 11697244
    [No Abstract]   [Full Text] [Related]  

  • 5. A cost-minimisation analysis comparing moxifloxacin with levofloxacin plus ceftriaxone for the treatment of patients with community-acquired pneumonia in Germany: results from the MOTIV trial.
    Lloyd A; Holman A; Evers T
    Curr Med Res Opin; 2008 May; 24(5):1279-84. PubMed ID: 18358083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Levofloxacin in the treatment of respiratory infections].
    Iakovlev SV; Iakovlev VP
    Antibiot Khimioter; 2002; 47(8):32-42. PubMed ID: 12515095
    [No Abstract]   [Full Text] [Related]  

  • 7. Implications of TeqCES: efficacy and safety of gatifloxacin in community-acquired pneumonia.
    Mandell LA; Jones RN
    Diagn Microbiol Infect Dis; 2002 Sep; 44(1):127-8. PubMed ID: 12376042
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical experience with levofloxacin in the treatment of pneumonia in ICU patients.
    Alvarez Lerma F;
    J Chemother; 2004 Apr; 16 Suppl 2():15-7. PubMed ID: 15255557
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical evaluation of oral levofloxacin 500 mg once-daily dosage for treatment of lower respiratory tract infections and urinary tract infections: a prospective multicenter study in China.
    Zhang YY; Huang HH; Ren ZY; Zheng HG; Yu YS; Lü XJ; Xiao ZK; Yang HF; Xiu QY; Chen BY; Yue HM; Hao QL; Huang JA; Ma H; Xiao W; Guo DY; Si B; Sun SH; Zhang W; Li QH; Shen HH; Duan J; Li HY; Yao WZ; Gu JM; Xia QM; Ying KJ; Liu A; Yang HP; Shi MH; Sun TY; Ding GH; Wu GM
    J Infect Chemother; 2009 Oct; 15(5):301-11. PubMed ID: 19856068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of gatifloxacin in community-acquired pneumonia: rationale for the Tequin Clinical Experience Study (TeqCES).
    Mandell LA
    Diagn Microbiol Infect Dis; 2002 Sep; 44(1):65-7. PubMed ID: 12376034
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of gemifloxacin 320 mg once-daily for 7 days in the treatment of adult lower respiratory tract infections.
    Ball P; File TM; Twynholm M; Henkel T
    Int J Antimicrob Agents; 2001 Jul; 18(1):19-27. PubMed ID: 11463522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind study comparing 5 days oral gemifloxacin with 7 days oral levofloxacin in patients with acute exacerbation of chronic bronchitis.
    Sethi S; Fogarty C; Fulambarker A
    Respir Med; 2004 Aug; 98(8):697-707. PubMed ID: 15303633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gatifloxacin in community-based treatment of acute respiratory tract infections in the elderly.
    Nicholson SC; High KP; Gothelf S; Webb CD
    Diagn Microbiol Infect Dis; 2002 Sep; 44(1):109-16. PubMed ID: 12376040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharma-clinics. The drug of the month. Levofloxacin (Tavanic)].
    Scheen AJ
    Rev Med Liege; 2000 Nov; 55(11):1015-7. PubMed ID: 11195704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Observational study investigating the use of levofloxacin in ICU patients].
    Alvarez-Lerma F; Palomar M; Olaechea P; León C; Sánchez M; Bermejo B;
    Enferm Infecc Microbiol Clin; 2004 Apr; 22(4):220-6. PubMed ID: 15056438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levofloxacin in patients with severe respiratory tract infection.
    Odagiri S
    Drugs; 1995; 49 Suppl 2():426-7. PubMed ID: 8549387
    [No Abstract]   [Full Text] [Related]  

  • 17. Full-course oral levofloxacin for treatment of hospitalized patients with community-acquired pneumonia.
    Erard V; Lamy O; Bochud PY; Bille J; Cometta A; Calandra T
    Eur J Clin Microbiol Infect Dis; 2004 Feb; 23(2):82-8. PubMed ID: 14727149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of community-acquired pneumonia with levofloxacin: 500 mg once a day or 500 mg twice a day?].
    Zuck P; Bru JP
    Presse Med; 2000 May 27-Jun 3; 29(19):1062-5. PubMed ID: 10874918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levofloxacin in the treatment of urinary tract infections and prostatitis.
    Naber KG
    J Chemother; 2004 Apr; 16 Suppl 2():18-21. PubMed ID: 15255558
    [No Abstract]   [Full Text] [Related]  

  • 20. New insights in the treatment by levofloxacin.
    File TM
    Chemotherapy; 2004; 50 Suppl 1():22-8. PubMed ID: 15319551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.